webinar register page

All fields are required

Your Information
Send to
Message preview	Hi there, You are invited to a Zoom webinar. When: Oct 31, 2020 09:55 AM Eastern Time (US and Canada) Topic: Community Markesbery Symposium Register in advance for this webinar: https://uky.zoom.us/webinar/register/WN_9hGJsRLzS8aC1BlA_DaCdw Or an H.323/SIP room system: H.323: 162.255.37.11 (US West) 162.255.36.11 (US East) 221.122.88.195 (China) 115.114.131.7 (India Mumbai) 115.114.115.7 (India Hyderabad) 213.19.144.110 (Amsterdam Netherlands) 213.244.140.110 (Germany) 103.122.166.55 (Australia) 209.9.211.110 (Hong Kong SAR) 64.211.144.160 (Brazil) 69.174.57.160 (Canada) 207.226.132.110 (Japan) Meeting ID: 914 6629 7532 SIP: 91466297532@zoomcrc.com After registering, you will receive a confirmation email containing information about joining the webinar. ---------- Webinar Speakers Maria Carrillo, PhD ("Advancing the Science: The Latest in Alzheimer’s and Dementia Research" @Alzheimer's Association) As chief science officer, Maria C. Carrillo, Ph.D., sets the strategic vision for the Alzheimer’s Association global research program. Under her leadership, the Association is the world’s largest nonprofit funder of Alzheimer’s research — investing more than $455 million since 1982 — and an internationally recognized pioneer in convening the dementia science community. Dr. Carrillo uses her platform as a noted public speaker to play an instrumental role in the Association’s efforts to lobby for increased funding for the disease. Dr. Carrillo oversees the implementation of the Association’s growing portfolio of research initiatives, including the Alzheimer’s Association International Conference® (AAIC®), the world’s largest and most influential dementia science meeting, and the Research Roundtable, which enables international scientific, industry and government leaders to work together to overcome shared obstacles in Alzheimer’s science and drug development. Daniela Moga, PhD ("My Medications and Why Should I Know about Them" @University of Kentucky) Dr. Moga is an Assistant Professor in the Department of Pharmacy Practice and Science and an affiliated faculty member in the Institute for Pharmaceutical Outcomes & Policy (IPOP). She also holds a joint appointment as Assistant Professor in the Department of Epidemiology in the College of Public Health. Dr. Moga received her M.D. and residency training in Epidemiology and Public Health from the University of Medicine and Pharmacy in Cluj-Napoca, Romania, and her Ph.D. in Epidemiology from the University of Iowa. Dr. Moga's areas of interest include pharmacoepidemiology and health outcomes research. Currently, her focus is on evaluating medication use and effects, including quality of life among the elderly with multiple comorbid conditions and/or in long-term care. Pete Nelson ("LATE: What It Is, Why It’s Important, and How We Might Beat It" @University of Kentucky) Peter Nelson, MD, PHD Professor & Director of Neuropathology, Department of Pathology and Laboratory Medicine; Neuropathology Core Director, UK Alzheimer’s Disease Center; Associate Director, Sanders-Brown Center on Aging Peter Nelson received his medical degree and a doctorate in philosophy in Neurobiology, from the University of Chicago Pritzker School of Medicine. He then completed anatomic pathology residency, neuropathology clinical fellowship, and post-doctoral fellowship at the University of Pennsylvania Medical Center, Philadelphia. Nelson is board certified by the American Board of Pathology in Anatomic Pathology and Neuropathology. He is director of neuropathology in the University of Kentucky Department of Pathology and Laboratory Medicine and leads the Neuropathology Core of the University of Kentucky Alzheimer's Disease Center.

Time Zone: